0
Clinical Investigations: AIRWAYS |

Zinc Chloride (Smoke Bomb) Inhalation Lung Injury*: Clinical Presentations, High-Resolution CT Findings, and Pulmonary Function Test Results

Hsian-He Hsu, MD; Ching Tzao, MD, PhD; Wei-Chou Chang, MD; Chin-Pyng Wu, MD, PhD; Ho-Jui Tung, PhD; Cheng-Yu Chen, MD; Wann-Cherng Perng, MD
Author and Funding Information

*From the Department of Radiology (Drs. Hsu, Chang, and Chen), the Department of Surgery (Dr. Tzao), Division of Thoracic Surgery, the Department of Internal Medicine (Drs. Wu and Perng), Division of Pulmonary and Critical Care Medicine, and the Department of Humanity and Social Studies (Dr. Tung), Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan, Republic of China.

Correspondence to: Wann-Cherng Perng, MD, Department of Internal Medicine, Division of Pulmonary and Critical Care Medicine, Tri-Service General Hospital, 325, Section 2, Nei Hu, Cheng Kung Rd, Taipei, Taiwan 114, ROC; e-mail: wperng@ms27.hinet.net



Chest. 2005;127(6):2064-2071. doi:10.1378/chest.127.6.2064
Text Size: A A A
Published online

Study objectives: Zinc chloride smoke inhalation injury (ZCSII) is uncommon and has been rarely described in previous studies. We hypothesized that structural changes of the lung might correlate with pulmonary function. To answer this question, we correlated findings from high-resolution CT (HRCT) scan and the results of pulmonary function tests (PFTs) in patients with ZCSII.

Design: Retrospective cohort study.

Setting: University hospital.

Patients: Twenty patients who had been hospitalized with ZCSII-related conditions.

Measurements: The study included HRCT scan scores (0 to 100), static and dynamic lung volumes, and diffusing capacity of the lung for carbon monoxide (Dlco).

Results: HRCT scans and PFTs were performed initially after injury (range, 3 to 21 days) in all patients and during the follow-up period (range, 27 to 66 days) in 10 patients. The predominant CT scan findings were patchy or diffuse ground-glass opacities with or without consolidation. The majority of patients showed a significant reduction of FVC, FEV1, total lung capacity, and Dlco, but normal FEV1/FVC ratio values. Changes of functional parameters correlated well with HRCT scan scores. Substantial improvements in CT scan abnormalities and pulmonary function were observed at follow-up.

Conclusions: The majority of our patients with ZCSII presented with a predominant parenchymal injury of the lung that was consistent with a restrictive type of functional impairment and a reduction in Dlco rather than with obstructive disease. Our results suggest that HRCT scanning and pulmonary function testing may reliably predict the severity of ZCSII.

Figures in this Article

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Figures

Tables

References

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Find Similar Articles
CHEST Journal Articles
PubMed Articles
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543